HIV infecting a human cell. Credit: NIH A new study suggests that a genetic switch that causes latent HIV inside cells to begin to replicate can be manipulated to completely eradicate the virus from the human body. Cells harboring latent HIV are “invisible” to the natural defenses of the immune system. The findings, which suggest […]Continue Reading ...
Millions of people have contracted Zika and chikungunya virus infections since the outbreaks that have been striking Latin America since 2013. Particularly Zika-related malformations in newborns warrant reliable diagnostics. DZIF scientists from the Charité – Universitätsmedizin Berlin demonstrate the problems with the currently available diagnostics, particularly for Zika virus detection, and develop combined testing methods […]Continue Reading ...
A cellular protein that interacts with invading viruses appears to help enable the infection process of the Zika virus, according to an international team of researchers who suggest this protein could be a key target in developing new therapies to prevent or treat Zika virus infection. Scientists first isolated Zika, a member of the Flaviviridae […]Continue Reading ...
Source: Centers for Disease Control and PreventionContinue Reading ...
Two groundbreaking discoveries by USC researchers could lead to medications and a vaccine to treat or prevent a hemorrhagic fever transmitted by a new tick species before it spreads across the United States. In the Jan. 7 Nature Microbiology, researchers describe the molecular mechanisms used by the virus to infect and sicken humans, a puzzle […]Continue Reading ...
A live vaccine genetically engineered from a common measles vaccine promises to be effective against the chikungunya virus. Such is the central finding of a recently completed Phase II trial now published in the prestigious journal “The Lancet”. Two MedUni Vienna departments were also involved in the study: Institute of Specific Prophylaxis and Tropical Medicine […]Continue Reading ...
A key step in retroviral growth inside a cell, as described by Jamil Saad, Ph.D., and colleagues, is portrayed on the cover of The Journal of Biological Chemistry. It is a visual image, in molecular detail, of their journal article inside that looks at avian sarcoma virus, or ASV. The University of Alabama at Birmingham […]Continue Reading ...
Scientists at the KU Leuven Rega Institute in Belgium have developed a new vaccine against the Zika virus. This vaccine should prevent the virus from causing microcephaly and other serious conditions in unborn babies. In 2015 and 2016, the world was shocked by the sudden and massive outbreak of the Zika virus in Latin America. […]Continue Reading ...
A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts. Scientists at Texas Biomedical Research Institute were part of a nationwide collaborative with scientists at Gladstone Institutes, […]Continue Reading ...
Scientists from academia, industry, and government have developed a combination of monoclonal antibodies (mAbs) that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe. The mAb “cocktail,” called MBP134, is the first experimental treatment to […]Continue Reading ...
Researchers from Singapore’s Duke-NUS Medical School, in collaboration with scientists in China, have identified and characterized a new genus of filovirus from a Rousettus bat in China. Their findings were published in the journal Nature Microbiology. Bat-borne viruses around the world pose a threat to human and animal health. Filoviruses, especially Ebola virus and Marburg […]Continue Reading ...
Dec 27 2018 A group of researchers led by Michael Diamond of Washington University in St. Louis have developed a vaccine that is effective in mice against Powassan virus, an emerging tick-borne virus that can cause life-threatening encephalitis in humans. They also show that the vaccine produces antibodies that can protect the mice against other, […]Continue Reading ...
Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus – it is their metabolic (or energy-producing) activity1 that enables the virus […]Continue Reading ...
A new compound that inhibits the replication of hepatitis C virus (HCV) in several stages of its lifecycle – and is also capable of acting on bacteria, fungi and cancer cells – has been synthesized by researchers at São Paulo State University (UNESP) in Brazil. The study was supported by São Paulo Research Foundation – […]Continue Reading ...
A study performed at the University of São Paulo’s Biomedical Science Institute (ICB-USP) in Brazil shows that sofosbuvir, a drug used to treat chronic hepatitis C, is capable of eliminating chikungunya virus and yellow fever virus. “Human cells infected by chikungunya virus were treated with sofosbuvir, and the drug eliminated the virus without damaging any […]Continue Reading ...
- Enemy number 1 – Air pollution and climate change top of WHO agenda
- Two Positive Phase III studies of Tafenoquine for the Radical Cure of Plasmodium vivax Malaria Published in The New England Journal of Medicine
- World Trade Center responders at increased risk for head and neck cancers
- Low-sugar diet leads to significant improvement in nonalcoholic fatty liver disease in boys
- Chaos in bodily regulation can optimize our immune system, finds study
- Short, text-based exercises can increase happiness for adults recovering from substance use disorders
- Body size may have greater influence on women’s lifespan than men
- Groundbreaking tool helps visualize neuronal activity with near-infrared light
- Scientists discover new genetic mutations causing inherited deaf-blindness
- UC team designs new naloxone-dispensing smart device
- Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
- Brain activity shows development of visual sensitivity in autism
- Two hour gap between dinner and sleep is overrated says Japanese research
- Fear and embarrassment are causing smear test numbers to plummet
- Protein-secreting device implanted in epileptic rats reduces seizures, improves cognition
- Reintroduction project recovers current wild population of green turtle in Cayman Islands
- Cancer survivors face greater financial burden related to medical bills
- PSA screening reduces prostate cancer deaths by 30%
- LSTM receives grant to help improve health of people living in informal settlements
- Hemochromatosis Mutation Linked to Other Morbidity